Browse by UCL Departments and Centres
![[up]](/style/images/multi_up.png)
Up a levelGroup by: Author | Type
Number of items: 381.
A
Aaboud, M;
Aad, G;
Abbott, B;
Abdinov, O;
Abeloos, B;
Abhayasinghe, DK;
Abidi, SH;
... Zwalinski, L; + view all
(2019)
Searches for scalar leptoquarks and differential cross-section measurements in dilepton-dijet events in proton-proton collisions at a centre-of-mass energy of root s=13TeV with the ATLAS experiment.
The European Physical Journal C
, 79
, Article 733. 10.1140/epjc/s10052-019-7181-x.
|
 |
|
Abeti, R;
Baccaro, A;
Giunti, P;
(2019)
Mitochondrial Dysfunction in Friedreich Ataxia.
In: Ahmad, SI, (ed.)
Handbook of Mitochondrial Dysfunction.
CRC Press: Boca Raton, FL, USA.
|
|
Abeyakoon, O;
Latifoltojar, A;
Gong, F;
Papoutsaki, M-V;
Chowdhury, R;
Glaser, M;
Jeraj, H;
... Punwani, S; + view all
(2019)
Hyperpolarised 13C MRI: a new horizon for non-invasive diagnosis of aggressive breast cancer.
BJR case reports
, 5
(3)
, Article 20190026. 10.1259/bjrcr.20190026.
|
|
|
Adeleke, S;
Latifoltojar, A;
Sidhu, H;
Galazi, M;
Shah, TT;
Clemente, J;
Davda, R;
... Punwani, S; + view all
(2019)
Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole-body magnetic resonance imaging in radio-recurrent prostate cancer.
BMC Medical Imaging
, 19
, Article 90. 10.1186/s12880-019-0380-y.
|
|
|
Agostinelli, C;
Akarca, AU;
Ramsay, A;
Rizvi, H;
Rodriguez-Justo, M;
Pomplun, S;
Proctor, I;
... Marafioti, T; + view all
(2019)
Novel markers in pediatric-type follicular lymphoma.
Virchows Archiv
10.1007/s00428-019-02681-y.
(In press).
|
|
|
Ahmad, SS;
Crittenden, MR;
Tran, PT;
Kluetz, PG;
Blumenthal, GM;
Bulbeck, H;
Baird, RD;
... Sharma, RA; + view all
(2019)
Clinical Development of Novel Drug–Radiotherapy Combinations.
Clinical Cancer Research
, 25
(5)
pp. 1455-1461.
10.1158/1078-0432.CCR-18-2466.
|
|
Ahmedzai, SH;
Snowden, JA;
Ashcroft, AJ;
Cairns, DA;
Williams, C;
Hockaday, A;
Cavenagh, JD;
... Cook, G; + view all
(2019)
Patient-Reported Outcome Results From the Open-Label, Randomized Phase III Myeloma X Trial Evaluating Salvage Autologous Stem-Cell Transplantation in Relapsed Multiple Myeloma.
Journal of Clinical Oncology
, 37
(19)
pp. 1617-1628.
10.1200/jco.18.01006.
|
|
|
Akintonde, A;
Grimes, H;
Moinuddin, S;
Sharma, RA;
McClelland, J;
Thielemans, K;
(2019)
EP-2067 Data driven region of interest respiratory surrogate signal extraction from CBCT data.
Presented at: 38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), Milan, Italy.
|
|
Akintonde, A;
Thielemans, K;
Sharma, R;
Mouches, P;
Mory, C;
Rit, S;
McClelland, J;
(2019)
Respiratory motion model derived from CBCT projection data.
In:
Proceedings of the 19th International Conference on the Use of Computers in Radiation Therapy.
ICCR
(In press).
|
|
Al-Mossawi, H;
Yager, N;
Taylor, CA;
Lau, E;
Danielli, S;
de Wit, J;
Gilchrist, J;
... Fairfax, BP; + view all
(2019)
Context-specific regulation of surface and soluble IL7R expression by an autoimmune risk allele.
Nature Communications
, 10
, Article 4575. 10.1038/s41467-019-12393-1.
|
|
|
Alifrangis, C;
McGovern, U;
Freeman, A;
Powles, T;
Linch, M;
(2019)
Molecular and histopathology directed therapy for advanced bladder cancer.
Nature Reviews Urology
, 16
(8)
pp. 465-483.
10.1038/s41585-019-0208-0.
|
|
|
Alzoubaidi, D;
Graham, D;
Bassett, P;
Magee, C;
Everson, M;
Banks, M;
Novelli, M;
... Haidry, R; + view all
(2019)
Comparison of two multiband mucosectomy devices for endoscopic resection of Barrett's esophagus-related neoplasia.
Surgical Endoscopy
, 33
pp. 3665-3672.
10.1007/s00464-018-06655-0.
|
|
|
Alzoubaidi, D;
Ragunath, K;
Wani, S;
Penman, ID;
Trudgill, NJ;
Jansen, M;
Banks, M;
... Haidry, R; + view all
(2019)
Quality indicators for Barrett's endotherapy (QBET): UK consensus statements for patients undergoing endoscopic therapy for Barrett's neoplasia.
Frontline Gastroenterology
10.1136/flgastro-2019-101247.
|
|
|
Amary, F;
Markert, E;
Berisha, F;
Ye, H;
Gerrand, C;
Cool, P;
Tirabosco, R;
... Flanagan, AM; + view all
(2019)
FOS Expression in Osteoid Osteoma and Osteoblastoma: A Valuable Ancillary Diagnostic Tool.
American Journal of Surgical Pathology
, 43
(12)
pp. 1661-1667.
10.1097/PAS.0000000000001355.
|
|
Amary, F;
Perez-Casanova, L;
Ye, H;
Cottone, L;
Strobl, A-C;
Cool, P;
Miranda, E;
... Flanagan, AM; + view all
(2019)
Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangement.
Modern Pathology
, 32
pp. 1762-1771.
10.1038/s41379-019-0315-8.
|
|
Anandagoda, N;
Willis, JC;
Hertweck, A;
Roberts, LB;
Jackson, I;
Gökmen, MR;
Jenner, RG;
... Lord, GM; + view all
(2019)
microRNA-142-mediated repression of phosphodiesterase 3B critically regulates peripheral immune tolerance.
Journal of Clinical Investigation
10.1172/JCI124725.
(In press).
|
|
|
Ankcorn, MJ;
Fox, TA;
Ijaz, S;
Nicholas, C;
Houston, E;
Longair, I;
Suri, D;
... Sekhar, M; + view all
(2019)
Characterising the risk of Hepatitis E virus infection in haematological malignancies: a UK prospective prevalence study.
British Journal of Haematology
, 186
(1)
pp. 191-195.
10.1111/bjh.15796.
|
|
Antas, P;
Novellasdemunt, L;
Kucharska, A;
Massie, I;
Carvalho, J;
Oukrif, D;
Nye, E;
... Li, VSW; + view all
(2019)
SH3BP4 Regulates Intestinal Stem Cells and Tumorigenesis by Modulating β-Catenin Nuclear Localization.
Cell Reports
, 26
(9)
2266-2273.e4.
10.1016/j.celrep.2019.01.110.
|
|
|
Aswendt, M;
Vogel, S;
Schaefer, C;
Jathoul, A;
Pule, M;
Hoehn, M;
(2019)
Quantitative in vivo dual-color bioluminescence imaging in the mouse brain.
Neurophotonics
, 6
(2)
, Article 025006. 10.1117/1.NPh.6.2.025006.
|
|
|
Attard, G;
Conteduca, V;
Wetterskog, D;
(2019)
A multimodal approach to outcome prediction in metastatic castration-resistant prostate cancer by integrating functional imaging and plasma DNA analysis.
JCO Precision Oncology
10.1200/PO.18.00302.
(In press).
|
|
Attard, G;
Jayaram, A;
Wingate, A;
Wetterskog, K;
(2019)
Plasma Androgen Receptor Copy Number Status at Emergence of Metastatic Castration-Resistant Prostate Cancer: A Pooled Multicohort Analysis.
JCO Precision Oncology
, 3
10.1200/PO.19.00123.
|
|
Attard, G;
Wetterskog, D;
Jayaram, A;
Wingate, A;
(2019)
Plasma AR status and cabazitaxel in heavily-treated metastatic castration-resistant prostate cancer.
European Journal of Cancer
, 116
pp. 158-168.
10.1016/j.ejca.2019.05.007.
|
|
Avenali, M;
Toffoli, M;
Mullin, S;
McNeil, A;
Hughes, DA;
Mehta, A;
Blandini, F;
(2019)
Evolution of prodromal parkinsonian features in a cohort of GBA mutation-positive individuals: a 6-year longitudinal study.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2019-320394.
(In press).
|
B
|
Bailey, C;
Bourne, RM;
Siow, B;
Johnston, EW;
Brizmohun Appayya, M;
Pye, H;
Heavey, S;
... Panagiotaki, E; + view all
(2019)
VERDICT MRI validation in fresh and fixed prostate specimens using patient-specific moulds for histological and MR alignment.
NMR in Biomedicine
, Article e4073. 10.1002/nbm.4073.
(In press).
|
|
|
Baker, A-M;
Gabbutt, C;
Williams, MJ;
Cereser, B;
Jawad, N;
Rodriguez-Justo, M;
Jansen, M;
... Wright, NA; + view all
(2019)
Crypt fusion as a homeostatic mechanism in the human colon.
Gut
10.1136/gutjnl-2018-317540.
(In press).
|
|
|
Banerjee, G;
Chan, E;
Ambler, G;
Wilson, D;
Cipolotti, L;
Shakeshaft, C;
Cohen, H;
... Vahidassr, D; + view all
(2019)
Effect of small-vessel disease on cognitive trajectory after atrial fibrillation-related ischaemic stroke or TIA.
Journal of Neurology
, 266
(5)
pp. 1250-1259.
10.1007/s00415-019-09256-6.
|
|
|
Banks, M;
Graham, D;
Jansen, M;
Gotoda, T;
Coda, S;
di Pietro, M;
Uedo, N;
... Dinis-Ribeiro, M; + view all
(2019)
British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma.
Gut
10.1136/gutjnl-2018-318126.
(In press).
|
|
|
Barber, PR;
Weitsman, G;
Lawler, K;
Barrett, J;
Rowley, M;
Rodriguez-Justo, M;
Fisher, D;
... Ng, T; + view all
(2019)
HER2-HER3 heterodimer quantification by FRET-FLIM and patient subclass analysis of the COIN colorectal trial.
JNCI: Journal of the National Cancer Institute
10.1093/jnci/djz231.
(In press).
|
|
|
Barrington, C;
Georgopoulou, D;
Pezic, D;
Varsally, W;
Herrero, J;
Hadjur, S;
(2019)
Enhancer accessibility and CTCF occupancy underlie asymmetric TAD architecture and cell type specific genome topology.
Nature Communications
, 10
, Article 2908. 10.1038/s41467-019-10725-9.
|
|
|
Barrington, SF;
Phillips, EH;
Counsell, N;
Hancock, B;
Pettengell, R;
Johnson, P;
Townsend, W;
... Radford, J; + view all
(2019)
Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study.
Journal of Clinical Oncology
, 37
(20)
pp. 1732-1741.
10.1200/JCO.18.01799.
|
|
|
Barrington, SF;
Phillips, EH;
Counsell, N;
Radford, J;
(2019)
Reply to H.J.A. Adams et al and C. Kobe et al.
Journal of Clinical Oncology
, 37
(34)
pp. 3325-3326.
10.1200/JCO.19.02056.
|
|
Barton, J;
Pacey, K;
Jain, N;
Kasia, T;
Edwards, D;
Thevanesan, C;
Straathof, K;
... Anderson, J; + view all
(2019)
Establishment and phenotyping of neurosphere cultures from primary neuroblastoma samples.
F1000Research
, 8
, Article 823. 10.12688/f1000research.18209.1.
|
|
|
Baumhoer, D;
Amary, F;
Flanagan, AM;
(2019)
An update of molecular pathology of bone tumors. Lessons learned from investigating samples by next generation sequencing.
Genes, Chromosomes and Cancer
, 58
(2)
pp. 88-99.
10.1002/gcc.22699.
|
|
Baumhoer, D;
Kovac, M;
Sperveslage, J;
Ameline, B;
Strobl, A-C;
Krause, A;
Trautmann, M;
... Hartmann, W; + view all
(2019)
Activating mutations in the MAP-kinase pathway define non-ossifying fibroma of bone.
The Journal of Pathology
, 248
(1)
pp. 116-122.
10.1002/path.5216.
|
|
Bazarbachi, A;
Boumendil, A;
Finel, H;
Mohty, M;
Castagna, L;
Blaise, D;
Peggs, KS;
... Sureda, A; + view all
(2019)
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party.
Cancer
, 125
(1)
pp. 90-98.
10.1002/cncr.31755.
|
|
Beaton, L;
Bandula, S;
Gaze, MN;
Sharma, RA;
(2019)
How rapid advances in imaging are defining the future of precision radiation oncology.
British Journal of Cancer
, 120
pp. 779-790.
10.1038/s41416-019-0412-y.
|
|
Beaton, L;
Bergman, A;
Nichol, A;
Aparicio, M;
Wong, G;
Gondara, L;
Speers, C;
... Tyldesley, S; + view all
(2019)
Cardiac death after breast radiotherapy and the QUANTEC cardiac guidelines.
Clinical and Translational Radiation Oncology
, 19
pp. 39-45.
10.1016/j.ctro.2019.08.001.
|
|
|
Beaton, L;
Tregidgo, HFJ;
Znati, SA;
Forsyth, S;
Clarkson, MJ;
Bandula, S;
Chouhan, M;
... Sharma, RA; + view all
(2019)
VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver Malignancies.
JMIR Research Protocols
, 8
(10)
, Article e13696. 10.2196/13696.
|
|
|
Beedham, W;
Peck, G;
Richardson, S;
Tsang, K;
Fertleman, M;
Shipway, D;
(2019)
Head injury in the elderly – an overview for the physician.
Clinical Medicine
, 19
(2)
pp. 177-184.
10.7861/clinmedicine.19-2-177.
|
|
Behjati, S;
Green, K;
Cheng, CWD;
(2019)
Fifteen Minute Consultation: Obvious and Not-So-Obvious Mediastinal Masses.
Archives of Disease in Childhood - Education & Practice edition
10.1136/archdischild-2018-315269.
|
|
|
Bell, CG;
Lowe, R;
Adams, PD;
Baccarelli, AA;
Beck, S;
Bell, JT;
Christensen, BC;
... Rakyan, VK; + view all
(2019)
DNA methylation aging clocks: challenges and recommendations.
Genome Biology
, 20
, Article 249. 10.1186/s13059-019-1824-y.
|
|
|
Bell, L;
Potts, H;
Williamson, E;
(2019)
P-17
Improving engagement in a health app: considerations in
designing a Micro-Randomised Trial.
Presented at: The 5th International Clinical Trials Methodology Conference (ICTMC 2019).
|
|
|
Beltran, M;
Tavares, M;
Justin, N;
Khandelwal, G;
Ambrose, J;
Foster, BM;
Worlock, KB;
... Jenner, RG; + view all
(2019)
G-tract RNA removes Polycomb repressive complex 2 from genes.
Nature Structural & Molecular Biology
, 26
pp. 899-909.
10.1038/s41594-019-0293-z.
|
|
Bennett, CL;
Ambler, CA;
(2019)
Editorial: Langerhans Cells and How Skin Pathology Reshapes the Local Immune Environment.
Frontiers in Immunology
, 10
, Article 139. 10.3389/fimmu.2019.00139.
|
|
|
Bentham, RB;
Bryson, K;
Szabadkai, G;
(2019)
Biclustering Analysis of Co-regulation Patterns in Nuclear-Encoded Mitochondrial Genes and Metabolic Pathways.
Cancer Metabolism
, 1928
pp. 469-478.
10.1007/978-1-4939-9027-6_24.
|
|
Bi, WL;
Hosny, A;
Schabath, MB;
Giger, ML;
Birkbak, NJ;
Mehrtash, A;
Allison, T;
... Aerts, HJWL; + view all
(2019)
Artificial intelligence in cancer imaging: Clinical challenges and applications.
CA: A Cancer Journal for Clinicians
, 69
(2)
pp. 127-157.
10.3322/caac.21552.
|
|
|
Bilanges, B;
Posor, Y;
Vanhaesebroeck, B;
(2019)
PI3K isoforms in cell signalling and vesicle trafficking.
Nature Reviews Molecular Cell Biology
, 20
pp. 515-534.
10.1038/s41580-019-0129-z.
|
|
Biswas, D;
Birkbak, NJ;
Rosenthal, R;
Hiley, CT;
Lim, EL;
Papp, K;
Boeing, S;
... TRACERx Consortium; + view all
(2019)
A clonal expression biomarker associates with lung cancer mortality.
Nature Medicine
, 25
pp. 1540-1548.
10.1038/s41591-019-0595-z.
|
|
Black, JR;
Goldin, RD;
Foxton, M;
Marafioti, T;
Akarca, AU;
Pria, AD;
Brock, C;
... Pinato, DJ; + view all
(2019)
PD-L1 expressing granulomatous reaction as an on-target mechanism of steroid-refractory immune hepatotoxicity.
Immunotherapy
, 11
(7)
pp. 585-590.
10.2217/imt-2018-0187.
|
|
Boire, A;
Coffelt, SB;
Quezada, SA;
Vander Heiden, MG;
Weeraratna, AT;
(2019)
Tumour Dormancy and Reawakening: Opportunities and Challenges.
Trends in Cancer
, 5
(12)
pp. 762-765.
10.1016/j.trecan.2019.10.010.
|
|
Boned Del Río, I;
Young, LC;
Sari, S;
Jones, GG;
Ringham-Terry, B;
Hartig, N;
Rejnowicz, E;
... Rodriguez-Viciana, P; + view all
(2019)
SHOC2 complex-driven RAF dimerization selectively contributes to ERK pathway dynamics.
Proceedings of the National Academy of Sciences of the United States of America
10.1073/pnas.1902658116.
(In press).
|
|
|
Boned del Río, Isabel;
(2019)
Therapeutic potential of SHOC2 via its selective contribution of the ERK pathway activation.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Bray, TJP;
Lopes, A;
Fisher, C;
Ciurtin, C;
Sen, D;
Hall-Craggs, MA;
(2019)
Sacroiliac Joint Ankylosis In Young Spondyloarthritis Patients Receiving Biologic Therapy: Observation of Serial MRI scans.
Arthritis and Rheumatology
, 71
(4)
pp. 594-598.
10.1002/art.40750.
|
|
Breeze, CE;
Reynolds, AP;
van Dongen, J;
Dunham, I;
Lazar, J;
Neph, S;
Vierstra, J;
... Beck, S; + view all
(2019)
eFORGE v2.0: updated analysis of cell type-specific signal in epigenomic data.
Bioinformatics
10.1093/bioinformatics/btz456.
(In press).
|
|
|
Bridgewater, J;
(2019)
Systemic treatment of biliary tract cancer: now we have evidence.
Annals of Oncology
, 30
(12)
pp. 1851-1852.
10.1093/annonc/mdz441.
|
|
Brown, P;
Tan, A-C;
El-Esawi, MA;
Liehr, T;
Blanck, O;
Gladue, DP;
Almeida, GMF;
... Shalchyan, V; + view all
(2019)
Large expert-curated database for benchmarking document similarity detection in biomedical literature search.
Database
pp. 1-66.
10.1093/database/baz085.
|
|
Budczies, J;
Allgäuer, M;
Litchfield, K;
Rempel, E;
Christopoulos, P;
Kazdal, D;
Endris, V;
... Stenzinger, A; + view all
(2019)
Optimizing panel-based tumor mutational burden (TMB) measurement.
Annals of Oncology
, 30
(9)
pp. 1496-1506.
10.1093/annonc/mdz205.
|
|
|
Bugeja, S;
Mistry, K;
Yim, IHW;
Tamimi, A;
Roberts, N;
Mundy, AR;
(2019)
A new Urethral Catheterisation Device (UCD) to manage Difficult Urethral Catheterisation.
World Journal of Urology
, 37
(4)
pp. 595-600.
10.1007/s00345-018-2499-9.
|
|
|
Burt, R;
Dey, A;
Aref, S;
Aguiar, M;
Akarca, A;
Bailey, K;
Day, W;
... Fielding, AK; + view all
(2019)
Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress.
Blood
, 134
(17)
pp. 1415-1429.
10.1182/blood.2019001398.
|
|
Burt, R;
Warcel, D;
Fielding, AK;
(2019)
Blinatumomab, a bispecific B-cell and T-cell engaging antibody, in the treatment of B-cell malignancies.
Human Vaccines & Immunotherapeutics
, 15
(3)
pp. 594-602.
10.1080/21645515.2018.1540828.
|
|
Buzzetti, E;
Hall, A;
Ekstedt, M;
Manuguerra, R;
Guerrero Misas, M;
Covelli, C;
Leandro, G;
... Tsochatzis, EA; + view all
(2019)
Collagen proportionate area is an independent predictor of long‐term outcome in patients with non‐alcoholic fatty liver disease.
Alimentary Pharmacology and Therapeutics
, 49
(9)
pp. 1214-1222.
10.1111/apt.15219.
|
C
|
Cailleau, T;
Adams, LR;
Arora, N;
Kang, G-D;
Masterson, L;
Patel, N;
Hartley, JA;
... Howard, PW; + view all
(2019)
Potentiation of PBD Dimers by Lipophilicity Manipulation.
Current Topics in Medicinal Chemistry
, 19
(9)
pp. 741-752.
10.2174/1568026619666190401112517.
|
|
Calaminus, G;
Jenney, M;
Hjorth, L;
Baust, K;
Bernstein, M;
Bielack, S;
Vos, PD;
... Nagarajan, R; + view all
(2019)
Quality of Life of Patients With Osteosarcoma in the European American Osteosarcoma Study-1 (EURAMOS-1): Development and Implementation of a Questionnaire Substudy.
JMIR Research Protocols
, 8
(9)
, Article e14406. 10.2196/14406.
|
|
|
Cappellini, MD;
Porter, J;
Origa, R;
Forni, GL;
Voskaridou, E;
Galacteros, F;
Taher, AT;
... Hermine, O; + view all
(2019)
Sotatercept, a novel transforming growth factor beta ligand trap, improves anemia in beta-thalassemia: a phase II, open-label, dose-finding study.
Haematologica
, 104
(3)
pp. 477-484.
10.3324/haematol.2018.198887.
|
|
|
Carter, Thomas James;
(2019)
Magnetic Hyperthermia for the Treatment of Glioblastoma.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Carters, R;
Cheraghchi-Bashi, A;
Westhorpe, A;
Yu, S;
Shanneik, Y;
Seraia, E;
Ouaret, D;
... Sharma, RA; + view all
(2019)
Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer.
Cancer Biology & Medicine
, 16
(2)
pp. 234-246.
10.20892/j.issn.2095-3941.2018.0284.
|
|
|
Chambers, P;
Jani, Y;
Wei, L;
Kipps, E;
Forster, MD;
Wong, ICK;
(2019)
Patient Factors and their Impact on Neutropenic Events: A Systematic review and meta-analysis.
Supportive Care in Cancer
, 27
(7)
pp. 2413-2424.
10.1007/s00520-019-04773-6.
|
|
Chan, JKY;
Gil-Farina, I;
Johana, N;
Rosales, C;
Tan, YW;
Ceiler, J;
Mcintosh, J;
... Mattar, CNZ; + view all
(2019)
Therapeutic expression of human clotting factors IX and X following adeno-associated viral vector-mediated intrauterine gene transfer in early-gestation fetal macaques.
FASEB Journal
, 33
(3)
pp. 3954-3967.
10.1096/fj.201801391R.
|
|
|
Chan, TA;
Yarchoan, M;
Jaffee, E;
Swanton, C;
Quezada, SA;
Stenzinger, A;
Peters, S;
(2019)
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic.
Annals of Oncology
, 30
(1)
pp. 44-56.
10.1093/annonc/mdy495.
|
|
|
Chandy, E;
Taylor, H;
Gaito, S;
Wells, E;
Jones, C;
Meehan, C;
Burland, H;
... Mandeville, H; + view all
(2019)
Hypofractionated Stereotactic Ablative Radiotherapy for Recurrent or Oligometastatic Tumours in Children and Young Adults.
Clinical Oncology
10.1016/j.clon.2019.11.005.
(In press).
|
|
|
Chang, J-M;
Floden, EW;
Herrero, J;
Gascuel, O;
Di Tommaso, P;
Notredame, C;
(2019)
Incorporating alignment uncertainty into Felsenstein’s phylogenetic bootstrap to improve its reliability.
Bioinformatics
10.1093/bioinformatics/btz082.
(In press).
|
|
Chauhan, N;
Mulcahy, MF;
Salem, R;
Benson Iii, AB;
Boucher, E;
Bukovcan, J;
Cosgrove, D;
... Sharma, RA; + view all
(2019)
TheraSphere Yttrium-90 Glass Microspheres Combined With Chemotherapy Versus Chemotherapy Alone in Second-Line Treatment of Patients With Metastatic Colorectal Carcinoma of the Liver: Protocol for the EPOCH Phase 3 Randomized Clinical Trial.
JMIR Research Protocols
, 8
(1)
, Article e11545. 10.2196/11545.
|
|
Chavda, SJ;
Maciocia, PM;
Mesiri, P;
Counsell, N;
Kothari, J;
Bird, A;
Mariner, C;
... Yong, K; + view all
(2019)
A new prognostic model for myeloma patients relapsing from upfront autologous transplantation based on ISS and PFS1.
British Journal of Haematology
, 185
(2)
pp. 350-353.
10.1111/bjh.15487.
|
|
Chemaly, RF;
Hill, JA;
Voigt, S;
Peggs, KS;
(2019)
In vitro comparison of currently available and investigational antiviral agents against pathogenic human double-stranded DNA viruses: A systematic literature review.
Antiviral Research
, 163
pp. 50-58.
10.1016/j.antiviral.2019.01.008.
|
|
|
Chemi, F;
Rothwell, DG;
McGranahan, N;
Gulati, S;
Abbosh, C;
Pearce, SP;
Zhou, C;
... TRACERx Consortium, .; + view all
(2019)
Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse.
Nature Medicine
, 25
pp. 1534-1539.
10.1038/s41591-019-0593-1.
|
|
Chen, W;
Morabito, SJ;
Kessenbrock, K;
Enver, T;
Meyer, KB;
Teschendorff, AE;
(2019)
Single-cell landscape in mammary epithelium reveals bipotent-like cells associated with breast cancer risk and outcome.
Communications Biology
, 2
, Article 306. 10.1038/s42003-019-0554-8.
|
|
|
Chen, X;
Zhabyeyev, P;
Azad, AK;
Wang, W;
Minerath, RA;
DesAulniers, J;
Grueter, CE;
... Oudit, GY; + view all
(2019)
Endothelial and cardiomyocyte PI3Kβ divergently regulate cardiac remodelling in response to ischaemic injury.
Cardiovascular Research
, 115
(8)
pp. 1343-1356.
10.1093/cvr/cvy298.
|
|
Chervova, O;
Conde, L;
Guerra-Assunção, JA;
Moghul, I;
Webster, AP;
Berner, A;
Larose Cadieux, E;
... Beck, S; + view all
(2019)
The Personal Genome Project-UK, an open access resource of human multi-omics data.
Scientific Data
, 6
, Article 257. 10.1038/s41597-019-0205-4.
|
|
|
Christen, F;
Hoyer, K;
Yoshida, K;
Hou, H-A;
Waldhueter, N;
Heuser, M;
Hills, RK;
... Damm, F; + view all
(2019)
Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients.
Blood
, 133
(10)
pp. 1140-1151.
10.1182/blood-2018-05-852822.
|
|
Chung, HC;
Arkenau, H-T;
Lee, J;
Rha, SY;
Oh, D-Y;
Wyrwicz, L;
Kang, Y-K;
... Safran, H; + view all
(2019)
Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial.
Journal for ImmunoTherapy of Cancer
, 7
, Article 30. 10.1186/s40425-019-0508-1.
|
|
|
Clamp, AR;
James, EC;
McNeish, IA;
Dean, A;
Kim, J-W;
O'Donnell, DM;
Hook, J;
... Ledermann, JA; + view all
(2019)
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.
The Lancet
10.1016/s0140-6736(19)32259-7.
|
|
|
Clarke, MA;
Fisher, J;
(2019)
Prognostic hallmarks in AML.
Nature Biomedical Engineering
, 3
(11)
pp. 847-849.
10.1038/s41551-019-0474-4.
|
|
Clarke, NW;
Ali, A;
Ingleby, FC;
Hoyle, A;
Amos, CL;
Attard, G;
Brawley, CD;
... James, ND; + view all
(2019)
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial.
Annals of Oncology
10.1093/annonc/mdz396.
(In press).
|
|
Cohen, H;
Mackie, IJ;
Devreese, KMJ;
(2019)
Clinical and laboratory practice for lupus anticoagulant testing: An International Society of Thrombosis and Haemostasis Scientific and Standardization Committee survey.
Journal of Thrombosis and Haemostasis
, 17
(10)
pp. 1715-1732.
10.1111/jth.14560.
|
|
Cohen, OC;
Counsell, N;
Rabin, N;
Popat, R;
Owen, RG;
Popova, B;
Schofield, O;
... Yong, KL; + view all
(2019)
Bortezomib consolidation post-ASCT as frontline therapy for multiple myeloma deepens disease response and MRD-negative rate whilst maintaining QOL and response to re-treatment at relapse.
[Letter].
British Journal of Haematology
, 185
(5)
pp. 948-951.
10.1111/bjh.15649.
|
|
Coleman, RL;
Ledermann, JA;
(2019)
Maintenance treatment for recurrent ovarian carcinoma – Evidence supporting the efficacy and safety of PARP inhibitors.
[Review].
European Oncology and Haematology
, 15
(1)
pp. 29-40.
10.17925/EOH.2019.15.1.29.
|
|
Colombo, N;
Sessa, C;
du Bois, A;
Ledermann, J;
McCluggage, WG;
McNeish, I;
Morice, P;
... Zeimet, AG; + view all
(2019)
ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease.
International Journal of Gynecological Cancer
, 29
(4)
pp. 728-760.
10.1136/ijgc-2019-000308.
|
|
|
Colombo, N;
Sessa, C;
du Bois, A;
Ledermann, J;
McCluggage, WG;
McNeish, I;
Morice, P;
... ESMO–ESGO Ovarian Cancer Consensus Conference Working Group, .; + view all
(2019)
ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease.
Annals of Oncology
, 30
(5)
pp. 672-705.
10.1093/annonc/mdz062.
|
|
Conesa, A;
Beck, S;
(2019)
Making multi-omics data accessible to researchers.
[Editorial comment].
Scientific Data
, 6
(1)
, Article 251. 10.1038/s41597-019-0258-4.
|
|
|
Conteduca, V;
Jayaram, A;
Romero-Laorden, N;
Wetterskog, D;
Salvi, S;
Gurioli, G;
Scarpi, E;
... de Giorgi, U; + view all
(2019)
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer.
European Urology
10.1016/j.eururo.2018.09.049.
(In press).
|
|
|
Cook, G;
Royle, K-L;
O'Connor, S;
Cairns, DA;
Ashcroft, AJ;
Williams, CD;
Hockaday, A;
... National Cancer Research Institute Haemato-oncology Clinical Stu; + view all
(2019)
The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.
British Journal of Haematology
10.1111/bjh.15782.
(In press).
|
|
|
Coombes, C;
Page, K;
Salari, R;
Hastings, RK;
Armstrong, AC;
Ahmed, S;
Ali, S;
... Shaw, JA; + view all
(2019)
Personalized detection of circulating tumor DNA antedates breast cancer metastatic recurrence.
Clinical Cancer Research
, 25
(14)
pp. 4255-4263.
10.1158/1078-0432.CCR-18-3663.
|
|
Coosemans, A;
Vankerckhoven, A;
Baert, T;
Boon, L;
Ruts, H;
Riva, M;
Blagden, S;
... Vergote, I; + view all
(2019)
Combining conventional therapy with immunotherapy: A risky business?
European Journal of Cancer
, 113
pp. 41-44.
10.1016/j.ejca.2019.02.014.
|
 |
|
Coughtrey, AE;
Shafran, R;
Su, MT;
Allcott-Watson, H;
Christie, D;
Hough, R;
(2019)
Health Professionals' Perspectives on the Nature of Distress and Low Mood in Young People with Cancer.
Journal of Adolescent and Young Adult Oncology
, 8
(2)
pp. 190-196.
10.1089/jayao.2018.0082.
|
|
Creary, LE;
Guerra, SG;
Chong, W;
Brown, CJ;
Turner, TR;
Robinson, J;
Bultitude, WP;
... Fernandez-Vina, MA; + view all
(2019)
Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: Report from the 17th International HLA and Immunogenetics Workshop.
Human Immunology
, 80
(7)
pp. 449-460.
10.1016/j.humimm.2019.03.001.
|
|
Crowley, C;
Butler, C;
Camilli, C;
Hynds, R;
Kolluri, KK;
Janes, SM;
De Coppi, P;
(2019)
Non-invasive longitudinal bioluminescence imaging of human mesoangioblasts in bioengineered esophagi.
Tissue Engineering Part C: Methods
, 25
(2)
pp. 103-113.
10.1089/ten.TEC.2018.0351.
|
|
|
Cuadrado, MM;
Szydlo, RM;
Watts, M;
Patel, N;
Renshaw, H;
Dorman, J;
Lowdell, M;
... Chakraverty, R; + view all
(2019)
Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function.
Haematologica
, 105
(11)
10.3324/haematol.2019.226340.
|
|
Cuff, AO;
Sillito, F;
Dertschnig, S;
Hall, A;
Tu, VL;
Chakraverty, R;
Male, V;
(2019)
The Obese Liver Environment Mediates Conversion of NK Cells to a Less Cytotoxic ILC1-Like Phenotype.
Frontiers in Immunology
, 10
, Article 2180. 10.3389/fimmu.2019.02180.
|
|
D
|
Dagil, L;
Troelsen, KS;
Bolt, G;
Thim, L;
Wu, B;
Zhao, X;
Tuddenham, EGD;
... Hansen, DF; + view all
(2019)
Interaction Between the a3 Region of Factor VIII and the TIL'E’ Domains of the von Willebrand Factor.
Biophysical Journal
, 117
(3)
pp. 479-489.
10.1016/j.bpj.2019.07.007.
|
|
|
Das-Gupta, E;
Thomson, KJ;
Bloor, AJC;
Clark, AD;
Mackinnon, S;
Kayani, I;
Clifton-Hadley, L;
... Peggs, KS; + view all
(2019)
Allo-HSCT in transplant-naive patients with Hodgkin lymphoma: a single-arm, multicenter study.
Blood Advances
, 3
(24)
pp. 4264-4270.
10.1182/bloodadvances.2019001016.
|
|
de Boer, SM;
Powell, ME;
Mileshkin, L;
Katsaros, D;
Bessette, P;
Haie-Meder, C;
Ottevanger, PB;
... Tubiana-Mathieu, N; + view all
(2019)
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial.
The Lancet Oncology
10.1016/S1470-2045(19)30395-X.
(In press).
|
|
|
de Bono, JS;
Concin, N;
Hong, DS;
Thistlethwaite, FC;
Machiels, J-P;
Arkenau, H-T;
Plummer, R;
... Lassen, U; + view all
(2019)
Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1-2 trial.
Lancet Oncology
, 20
(3)
pp. 383-393.
10.1016/S1470-2045(18)30859-3.
|
|
Dehbi, H-M;
Mallick, U;
Wadsley, J;
Newbold, K;
Harmer, C;
Hackshaw, A;
(2019)
Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial.
Lancet Diabetes and Endocrinology
, 7
(1)
pp. 44-51.
10.1016/S2213-8587(18)30306-1.
|
|
|
Dillon, MT;
Grove, L;
Newbold, KL;
Shaw, H;
Brown, NF;
Mendell, J;
Chen, S;
... Harrington, KJ; + view all
(2019)
Patritumab with Cetuximab plus Platinum-Containing Therapy in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: An Open-Label, Phase Ib Study.
Clinical Cancer Research
, 25
(2)
pp. 487-495.
10.1158/1078-0432.CCR-18-1539.
|
|
Dodagatta-Marri, E;
Meyer, DS;
Reeves, MQ;
Paniagua, R;
To, MD;
Binnewies, M;
Broz, ML;
... Akhurst, RJ; + view all
(2019)
α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas.
Journal for ImmunoTherapy of Cancer
, 7
, Article 62. 10.1186/s40425-018-0493-9.
|
|
|
Donald, A;
Cizer, H;
Finnegan, N;
Collin-Histed, T;
Hughes, DA;
Davies, EH;
(2019)
Measuring disease activity and patient experience remotely using wearable technology and a mobile phone app: outcomes from a pilot study in Gaucher disease.
Orphanet Journal of Rare Diseases
, 14
, Article 212. 10.1186/s13023-019-1182-6.
|
|
|
Drayson, MT;
Bowcock, S;
Planche, T;
Iqbal, G;
Pratt, G;
Yong, K;
Wood, J;
... Dunn, JA; + view all
(2019)
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.
The Lancet Oncology
, 20
(12)
pp. 1760-1772.
10.1016/S1470-2045(19)30506-6.
|
|
|
Drayson, MT;
Bowcock, S;
Planche, T;
Iqbal, G;
Pratt, G;
Yong, K;
Wood, J;
... Dunn, JA; + view all
(2019)
Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT.
Health Technology Assessment
, 23
(62)
10.3310/hta23620.
|
|
|
Dufek, S;
Cheshire, C;
Levine, AP;
Trompeter, RS;
Issler, N;
Stubbs, M;
Mozere, M;
... Bockenhauer, D; + view all
(2019)
Genetic identification of two novel loci associated with steroid-sensitive nephrotic syndrome.
Journal of the American Society of Nephrology
, 30
(8)
pp. 1375-1384.
10.1681/ASN.2018101054.
|
 |
|
Dyke, SOM;
Saulnier, KM;
Dupras, C;
Webster, AP;
Maschke, K;
Rothstein, M;
Siebert, R;
... Joly, Y; + view all
(2019)
Points-to-consider on the return of results in epigenetic research.
Genome Medicine
, 11
(1)
, Article 31. 10.1186/s13073-019-0646-6.
|
|
E
|
Ecker, S;
Beck, S;
(2019)
The epigenetic clock: a molecular crystal ball for human aging?
Aging (Albany NY)
, 11
(2)
pp. 833-835.
10.18632/aging/101712.
|
|
|
Efthymiou, M;
Mackie, IJ;
Lane, PJ;
Andrade, D;
Willis, R;
Erkan, D;
Sciascia, S;
... APS ACTION, .; + view all
(2019)
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository.
Journal of Thrombosis and Haemostasis
, 17
(12)
pp. 2069-2080.
10.1111/jth.14596.
|
|
El-Sharkawi, D;
Ng, C-H;
Payne, EMC;
Yong, KL;
Ardeshna, KM;
Khwaja, A;
Townsend, W;
(2019)
Clinical outcomes and survival of patients with myeloma and lymphoma enrolled into phase I clinical trials.
British Journal of Haematology
, 185
(2)
pp. 344-347.
10.1111/bjh.15457.
|
|
Embleton-Thirsk, A;
Deane, E;
Townsend, S;
Farrelly, L;
Popoola, B;
Parker, J;
Rustin, G;
... Kaplan, R; + view all
(2019)
Impact of retrospective data verification to prepare the ICON6 trial for use in a marketing authorization application.
Clinical Trials
, 16
(5)
pp. 502-511.
10.1177/1740774519862528.
|
|
|
Engelhardt, M;
Yong, K;
Bringhen, S;
Waesch, R;
(2019)
Carfilzomib combination treatment as first-line therapy in multiple myeloma: where do we go from the Carthadex (KTd)-trial update?
[Editorial comment].
Haematologica
, 104
(11)
pp. 2128-2131.
10.3324/haematol.2019.228684.
|
|
|
Evans, R;
Flores-Borja, F;
Nassiri, S;
Miranda, E;
Lawler, K;
Grigoriadis, A;
Monypenny, J;
... Ng, T; + view all
(2019)
Integrin-Mediated Macrophage Adhesion Promotes Lymphovascular Dissemination in Breast Cancer.
Cell Reports
, 27
(7)
1967-1978.e4.
10.1016/j.celrep.2019.04.076.
|
|
|
Evans, RDR;
Cargill, T;
Goodchild, G;
Oliveira, B;
Rodriguez-Justo, M;
Pepper, R;
Connolly, J;
... Culver, EL; + view all
(2019)
Clinical Manifestations and Long-term Outcomes of IgG4-Related Kidney and Retroperitoneal Involvement in a United Kingdom IgG4-Related Disease Cohort.
Kidney International Reports
, 4
(1)
pp. 48-58.
10.1016/j.ekir.2018.08.011.
|
|
|
Evans, REC;
Taylor, SA;
Kalasthry, J;
Sakai, NS;
Miles, A;
Streamline investigators;
(2019)
Patient deprivation and perceived scan burden negatively impact the quality of whole-body MRI.
Clinical Radiology
10.1016/j.crad.2019.10.019.
(In press).
|
|
|
Evans, TRJ;
Dean, E;
Molife, LR;
Lopez, J;
Ranson, M;
El-Khouly, F;
Zubairi, I;
... Kristeleit, R; + view all
(2019)
Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours.
British Journal of Cancer
, 120
pp. 379-386.
10.1038/s41416-019-0377-x.
|
|
|
Eyre, TA;
Kirkwood, AA;
Gohill, S;
Follows, G;
Walewska, R;
Walter, H;
Cross, M;
... the UK CLL Forum; + view all
(2019)
Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post-BCR inhibitor setting: a UK wide analysis.
British Journal of Haematology
, 185
(4)
pp. 656-669.
10.1111/bjh.15802.
|
|
Eyre, TA;
Kirkwood, AA;
Wolf, J;
Hildyard, C;
Mercer, C;
Plaschkes, H;
Griffith, J;
... Hatton, CSR; + view all
(2019)
Stand-alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R-CHOP and is associated increased infection-related toxicity.
British Journal of Haematology
, 187
(2)
pp. 185-194.
10.1111/bjh.16070.
|
|
F
|
Fang, C;
Virdee, S;
Jacob, J;
Rufai, O;
Agarwal, K;
Quaglia, A;
Quinlan, DJ;
(2019)
Strain elastography for noninvasive assessment of liver fibrosis: A prospective study with histological comparison.
Ultrasound
, 27
(4)
pp. 262-271.
10.1177/1742271X19862836.
|
|
|
Ferrer, IR;
West, HC;
Henderson, S;
Ushakov, DS;
Santos E Sousa, P;
Strid, J;
Chakraverty, R;
... Bennett, CL; + view all
(2019)
A wave of monocytes is recruited to replenish the long-term Langerhans cell network after immune injury.
Science Immunology
, 4
(38)
, Article eaax8704. 10.1126/sciimmunol.aax8704.
|
|
|
Fielding, AK;
(2019)
Curing Ph+ ALL: assessing the relative contributions of chemotherapy, TKIs, and allogeneic stem cell transplant.
Hematology, the ASH Education Program
, 2019
(1)
pp. 24-29.
10.1182/hematology.2019000010.
|
|
Fielding, AK;
(2019)
En-Abl-ing treatment of “Ph-like” ALL?
Blood
, 134
(16)
pp. 1277-1278.
10.1182/blood.2019002621.
|
|
Fittall, MW;
Van Loo, P;
(2019)
Translating insights into tumor evolution to clinical practice: promises and challenges.
Genome Medicine
, 11
, Article 20. 10.1186/s13073-019-0632-z.
|
|
Forster, MD;
Dillon, MT;
Kocsis, J;
Remenár, É;
Pajkos, G;
Rolland, F;
Greenberg, J;
(2019)
Patritumab or placebo, with cetuximab plus platinum therapy in recurrent or metastatic squamous cell carcinoma of the head and neck: A randomised phase II study.
European Journal of Cancer
, 123
pp. 36-47.
10.1016/j.ejca.2019.08.017.
|
|
|
Fox, TA;
Carpenter, B;
Khwaja, A;
Halsey, R;
Grandage, V;
Mansour, MR;
Fielding, AK;
(2019)
Utility of FDG-PET/CT in Lymphoblastic Lymphoma.
Presented at: 61st ASH Annual Meeting, Orlando, FL, USA.
|
|
Foxall, E;
Staszowska, A;
Hirvonen, LM;
Georgouli, M;
Ciccioli, M;
Rimmer, A;
Williams, L;
... Wells, CM; + view all
(2019)
PAK4 Kinase Activity Plays a Crucial Role in the Podosome Ring of Myeloid Cells.
Cell Reports
, 29
(11)
3385-3393.e6.
10.1016/j.celrep.2019.11.016.
|
|
|
Franz Demane, Dafne Sofia;
(2019)
Defining and targeting combination immunotherapies in mouse models of cancer.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Frizziero, M;
Wang, X;
Chakrabarty, B;
Childs, A;
Luong, TV;
Walter, T;
Khan, MS;
... McNamara, MG; + view all
(2019)
Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres.
World Journal of Gastroenterology
, 25
(39)
pp. 5991-6005.
10.3748/wjg.v25.i39.5991.
|
|
|
Fujimitsu, K;
Yamano, H;
(2019)
PP2A-B56 binds to Apc1 and promotes Cdc20 association with the APC/C ubiquitin ligase in mitosis.
EMBO Reports
, Article e48503. 10.15252/embr.201948503.
(In press).
|
|
|
Furniss, D;
Mayer, A;
Franklin, BD;
Blandford, A;
(2019)
Exploring structure, agency and performance variability in everyday safety: An ethnographic study of practices around infusion devices using distributed cognition.
Safety Science
, 118
pp. 687-701.
10.1016/j.ssci.2019.06.006.
|
|
G
|
Gaifulina, R;
Caruana, DJ;
Oukrif, D;
Guppy, NJ;
Culley, S;
Brown, R;
Bell, I;
... Thomas, GMH; + view all
(2019)
Rapid and complete paraffin removal from human tissue sections delivers enhanced Raman spectroscopic and histopathological analysis.
Analyst
10.1039/c9an01030k.
(In press).
|
|
|
Gardiner, C;
Lane, P;
Tailor, H;
Mackie, IJ;
(2019)
A practical method for reducing the interference due to lipaemia in coagulation tests.
International Journal of Laboratory Hematology
, 42
(2)
pp. 140-144.
10.1111/ijlh.13129.
|
|
|
Germain, DP;
Arad, M;
Burlina, A;
Elliott, PM;
Falissard, B;
Feldt-Rasmussen, U;
Hilz, MJ;
... Spada, M; + view all
(2019)
The effect of enzyme replacement therapy on clinical outcomes in female patients with Fabry disease - A systematic literature review by a European panel of experts.
Molecular Genetics and Metabolism
, 126
(3)
pp. 224-235.
10.1016/j.ymgme.2018.09.007.
|
|
|
Germain, DP;
Nicholls, K;
Giugliani, R;
Bichet, DG;
Hughes, DA;
Barisoni, LM;
Colvin, RB;
... Viereck, C; + view all
(2019)
Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study.
Genetics in Medicine
10.1038/s41436-019-0451-z.
(In press).
|
|
|
Ghorashian, S;
Kramer, AM;
Onuoha, S;
Wright, G;
Bartram, J;
Richardson, R;
Albon, SJ;
... Amrolia, PJ; + view all
(2019)
Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR.
Nature Medicine
, 25
pp. 1408-1414.
10.1038/s41591-019-0549-5.
|
|
Glaire, MA;
Domingo, E;
Sveen, A;
Bruun, J;
Nesbakken, A;
Nicholson, G;
Novelli, M;
... Church, DN; + view all
(2019)
Tumour-infiltrating CD8^{+} lymphocytes and colorectal cancer recurrence by tumour and nodal stage.
British Journal of Cancer
, 121
pp. 474-482.
10.1038/s41416-019-0540-4.
|
|
Glaser, M;
Rajkumar, V;
Diocou, S;
Gendron, T;
Yan, R;
Sin, PKB;
Sander, K;
... Arstad, E; + view all
(2019)
One-Pot Radiosynthesis and Biological Evaluation of a Caspase-3 Selective 5-[¹²³,¹²⁵I]iodo-1,2,3-triazole derived Isatin SPECT Tracer.
Scientific Reports
, 9
, Article 19299. 10.1038/s41598-019-55992-0.
|
|
|
Gökbuget, N;
Kantarjian, HM;
Brüggemann, M;
Stein, AS;
Bargou, RC;
Dombret, H;
Fielding, AK;
... Topp, MS; + view all
(2019)
Molecular response with blinatumomab in relapsed/refractory B-cell precursor acute lymphoblastic leukemia.
Blood Advances
, 3
(20)
pp. 3033-3037.
10.1182/bloodadvances.2019000457.
|
|
|
Golan, T;
Hammel, P;
Reni, M;
Van Cutsem, E;
Macarulla, T;
Hall, MJ;
Park, J-O;
... Kindler, HL; + view all
(2019)
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.
The New England Journal of Medicine
, 381
pp. 317-327.
10.1056/NEJMoa1903387.
|
|
González Martín, A;
Oza, A;
Embleton, AC;
Pfisterer, J;
Ledermann, J;
Pujade-Lauraine, E;
Kristensen, G;
... Perren, T; + view all
(2019)
Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer.
Gynecologic Oncology
, 152
(1)
10.1016/j.ygyno.2018.08.036.
|
|
|
González-Billalabeitia, E;
Conteduca, V;
Wetterskog, D;
Jayaram, A;
Attard, G;
(2019)
Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented test.
Prostate Cancer and Prostatic Diseases
, 22
pp. 195-205.
10.1038/s41391-018-0098-x.
|
|
Gore, M;
Hackshaw, A;
Brady, WE;
Penson, RT;
Zaino, R;
McCluggage, WG;
Ganesan, R;
... Gershenson, DM; + view all
(2019)
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor.
Gynecologic Oncology
, 153
(3)
pp. 541-548.
10.1016/j.ygyno.2019.03.256.
|
|
|
Goswami, P;
Oliva, EN;
Ionova, T;
Else, R;
Kell, J;
Fielding, AK;
Jennings, DM;
... Salek, S; + view all
(2019)
Paper and electronic versions of HM-PRO, a novel patient-reported outcome measure for hematology: an equivalence study.
Journal Of Comparative Effectiveness Research
, 8
(7)
pp. 523-533.
10.2217/cer-2018-0108.
|
|
|
Gourley, C;
Balmaña, J;
Ledermann, JA;
Serra, V;
Dent, R;
Loibl, S;
Pujade-Lauraine, E;
(2019)
Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer Therapy.
Journal of Clinical Oncology
, 37
(25)
pp. 2257-2269.
10.1200/JCO.18.02050.
|
|
Granai, M;
Ambrosio, MR;
Akarca, A;
Mundo, L;
Vergoni, F;
Santi, R;
Mancini, V;
... Lazzi, S; + view all
(2019)
Role of Epstein Barr virus in transformation of follicular lymphoma to diffuse large B-cell lymphoma: a case report and review of the literature.
Haematologica
10.3324/haematol.2018.215053.
|
|
|
Greenwood, HE;
McCormick, PN;
Gendron, T;
Glaser, M;
Pereira, R;
Maddocks, ODK;
Sander, K;
... Witney, TH; + view all
(2019)
Measurement of Tumor Antioxidant Capacity and Prediction of Chemotherapy Resistance in Preclinical Models of Ovarian Cancer by Positron Emission Tomography.
Clinical Cancer Research
, 25
(8)
pp. 2471-2482.
10.1158/1078-0432.CCR-18-3423.
|
|
Gupta, RK;
Abdul-Jawad, S;
McCoy, LE;
Mok, HP;
Peppa, D;
Salgado, M;
Martinez-Picado, J;
... Olavarria, E; + view all
(2019)
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation.
Nature
, 568
pp. 244-249.
10.1038/s41586-019-1027-4.
|
H
| Hagos, YB; Narayanan, PL; Akarca, AU; Marafioti, T; Yuan, Y; (2019) |